Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense Oligonucleotides

This publication has 32 references indexed in Scilit:

• Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense
  American Journal of Human Genetics, 2004
• Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
  Human Molecular Genetics, 2003
• Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
  Neuromuscular Disorders, 2002
• Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Δ48-50 DMD cells
  Proceedings of the National Academy of Sciences, 2002
• Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy
  Neurology, 1998
• Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides
  Human Molecular Genetics, 1998
• Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
  Nature, 1990
• Characterization of Dystrophin in Muscle-Biopsy Specimens from Patients with Duchenne's or Becker's Muscular Dystrophy
  New England Journal of Medicine, 1988
• An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus
  Genomics, 1988
• Dystrophin: The protein product of the duchenne muscular dystrophy locus
  Cell, 1987